E P Diamandis

No ORCID on file · 4 papers in corpus
other 2013
Clinical biochemistry ·doi:10.1016/j.clinbiochem.2013.03.010

OBJECTIVES: Ovarian cancer is the most lethal gynecological malignancy in North America. Although survival rates are high when the disease is diagnosed at an early stage, this decreases exponentially in late-stage diagnoses. As such, there …

other 2012
Clinical biochemistry ·doi:10.1016/j.clinbiochem.2012.08.011

OBJECTIVES: To measure the levels of serum CUB and zona pellucida-like domain-containing protein 1 (CUZD1) in patients with ovarian cancer (OvCa), benign gynecological conditions and healthy women and in a number of other cancer types (brea…

other 2008
British journal of cancer ·doi:10.1038/sj.bjc.6604630

Currently, there are no effective biomarkers for ovarian cancer prognosis or prediction of therapeutic response. The objective of this study was to examine a panel of 10 serum biochemical parameters for their ability to predict response to …

other 2007
British journal of cancer ·doi:10.1038/sj.bjc.6603556

The human tissue kallikrein family (KLK for protein; KLK for gene) includes 15 members. Twelve kallikreins, including KLK6, are concurrently upregulated in ovarian cancer. However, the mechanism of this phenomenon remains unclear. In this s…